Vanguard Fiduciary Trust
INDP icon

Vanguard Fiduciary Trust’s Indaptus Therapeutics INDP Stock Holding History

Vanguard Fiduciary Trust’s Portfolio INDP Stock Details INDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.9K Buy
+13,967
New +$35.2K ﹤0.01% 3903

Other funds holding INDP

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Vanguard Fiduciary Trust's INDP Position: Q2 2026 in Review

Vanguard Fiduciary Trust opened a new position in Indaptus Therapeutics (INDP) in Q2 2026: 13,967 shares worth $41.9K. The stake represents ﹤0.01% of the portfolio and ranks #3903 among its holdings.

9 funds tracked by Wall St. Rank hold INDP as of Q2 2026.

  • Vanguard Fiduciary Trust held 13,967 shares of Indaptus Therapeutics worth $41.9K as of Q2 2026.
  • Indaptus Therapeutics was a new Vanguard Fiduciary Trust position in Q2 2026.
  • Indaptus Therapeutics made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3903 holding.
  • 9 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.